Table 3. Correlation according to 18F-FDG uptake (n=34).
| Spearman r | 95% CI | P-value | |
|---|---|---|---|
| LAT1 |
0.664 |
0.411–0.822 |
<0.001 |
| CD98 |
0.734 |
0.519–0.862 |
<0.001 |
| Glut1 |
0.616 |
0.341–0.794 |
<0.001 |
| Ki-67 |
0.399 |
0.061–0.656 |
0.019 |
| CD34 |
0.357 |
−0.057–0.568 |
0.036 |
| EGFR |
0.197 |
−0.161–0.501 |
0.263 |
| p-Akt |
−0.093 |
−0.427–0.267 |
0.599 |
| p-mTOR | −0.159 | −0.181–0.0.199 | 0.367 |
Abbreviations: 95% CI=95% confidence interval; EGFR=epidermal growth receptor factor; 18F-FAMT=L-[3-18F]-α–methyltyrosine; Glut1=glucose transporter 1; LAT1=L-type amino-acid transporter 1; p-mTOR=phospho-mammalian targeting of rapamycin. The bold entries show statistically significant difference.